Research ArticleClinical Investigation
Value of FDG PET in Papillary Thyroid Carcinoma with Negative 131I Whole-Body Scan
June-Key Chung, Young So, Jae Sung Lee, Chang Woon Choi, Sang Moo Lim, Dong Soo Lee, Sung Woon Hong, Yeo Kyu Youn, Myung Chul Lee and Bo Youn Cho
Journal of Nuclear Medicine June 1999, 40 (6) 986-992;
June-Key Chung
Young So
Jae Sung Lee
Chang Woon Choi
Sang Moo Lim
Dong Soo Lee
Sung Woon Hong
Yeo Kyu Youn
Myung Chul Lee


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Value of FDG PET in Papillary Thyroid Carcinoma with Negative 131I Whole-Body Scan
June-Key Chung, Young So, Jae Sung Lee, Chang Woon Choi, Sang Moo Lim, Dong Soo Lee, Sung Woon Hong, Yeo Kyu Youn, Myung Chul Lee, Bo Youn Cho
Journal of Nuclear Medicine Jun 1999, 40 (6) 986-992;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery
- Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management
- The contribution of PET/CT to improved patient management
- PET in the follow-up of differentiated thyroid cancer
- Sodium Iodide Symporter: Its Role in Nuclear Medicine
- The thyroid gland
- Clinical Impact of 18F-FDG PET in Thyroid Carcinoma Patients with Elevated Thyroglobulin Levels and Negative 131I Scanning Results After Therapy
- Advances in radionuclide imaging: radionuclide imaging as a guide to therapy
- A Tabulated Summary of the FDG PET Literature
- Influence of Thyroid-Stimulating Hormone Levels on Uptake of FDG in Recurrent and Metastatic Differentiated Thyroid Carcinoma